Now that we have smart news about Pfizer’s coronavirus vaccine, the next big problem is: when are we going to get it?
First, it is vital that Pfizer has not published the effects in a peer-reviewed medical journal and still wants to download emergency use approval from the Food and Drug Administration (FDA).
Although the Pfizer vaccine receives emergency use approval from the FDA, the process of development, testing, manufacturing, distribution, storage and administration of the COVID-19 vaccine is rapid
And fitness officers still need to know who’s going to get vaccinated first.
The maximum organization that is likely to get the vaccine first are frontline physical care workers, followed by high-risk people and the elderly.
Pfizer will have about 50 million doses of vaccine at first, so it will be several months before the vaccine reaches the population.
Health experts expect vaccines to begin in December, before spreading to other high-risk teams by the end of the first quarter of 2021.
“It will be an ongoing effort in the many months of 2021. No we can do it in a week and a half,” said Dr. William Schaffner, medical director of the National Infectious Diseases Foundation at Healthline.
The Pfizer vaccine test is still complete.
There are still a few weeks left to collect more security data.
At this point, estimated around the third week of November, the pharmaceutical company expects to send its findings to the FDA for emergency use authorization (USA).
“The FDA will review in less than four weeks and, if granted the U. S. , it could publish the distribution as soon as late December,” said Dr. Onyema Ogbuagu, an infectious disease specialist at Yale Medicine and an associate professor of medicine who is the lead researcher in the Pfizer trial at yale Medical School.
Assuming everything goes well with the review and approval process, Schaffner said the first deployment of the vaccine could begin last December.
The distribution and garage of the Pfizer vaccine is confusing because it will have to be stored at freezing temperatures, around -70 degrees Celsius (-94 degrees Fahrenheit).
“There will be really demanding logistical and organizational situations here,” Schaffner said.
Dosages will be distributed in predetermined locations (established through state fitness service) in dry ice boxes.
Once vaccine doses are successful at their final location (a hospital, nursing home, or retail pharmacy), they can be placed on new dry ice or stored in cooling units.
According to Schaffner, some state fitness facilities may invest in cellular equipment to administer vaccines at sites, such as nursing homes and hospitals.
“Get your popcorn because it may only be the best orchestration and coordination,” said Dr. Daniel Fagbuyi, an emergency physician who served as a biodefensal expert in the Obama administration.
Pfizer is estimated to produce approximately 50 million doses until the end of the year.
The vaccine is given in two doses, 21 days apart. This means that only 25 million more people will have to make the first batch.
“People will take priority to complete their series, their two-dose series, before moving on to the person, because it takes two doses to provide protection,” Schaffner said.
Health officials are still wondering exactly who will get the vaccine first.
Schaffner expects other teams to be prioritized in other parts of the country.
While this precedence has yet to be confirmed, Schaffer said that physical care staff in nursing homes and first responders are likely to be the first organization to get vaccinated.
Pfizer expects to have more than a billion doses by 2021.
When more doses are available in 2021, the next high-priority organization, which may simply be high-risk seniors or essential staff, will be vaccinated.
Between February and March, there will be enough doses to succeed in those other high-priority segments, Schaffner said.
The opportunity for the general population to be vaccinated may be given in mid-to-late 2021.
“[It will take] 3 to 6 months due to production and distribution problems,” Ogbuagu said. “And [the requirement] of two doses means that many doses are needed. “
Fagbuyi said the vaccine could start reaching the general population around March or April.
It is possible that it is simply “in full swing until June 2021, given the concatenation of logistical obstacles and an inevitable margin of error,” Fagbuyi said.
Another explanation for why it is difficult to determine the precise timing of the COVID-19 vaccine is that some others might be skeptical about vaccination.
“There is a lot of skepticism and unholy among all medical professions, as in the general population,” Schaffner said.
In some places, there would possibly be enough unclaimed doses in the initial batch for others at the time the precedence teams are emptensed.
Local fitness officials will want to be flexible.
“If you can’t get rid of the vaccine in organization one, if there are enough receptors, then you’d like to move on to organization two because there’s no point keeping the vaccine unused in the fridge,” Schaffner said. likes to put the vaccine in arms. “
And other people will still have to wear masks as masks even after they have been vaccinated.
The effectiveness of 90% of the vaccine is a wonderful success, but it still means that there is a 10% chance that other people who get the vaccine will get the infection.
It is also known whether the vaccine prevents transmission of the virus or prevents the disease.
These answers will come later next year.
“We will continue to have to wear a mask for ourselves and others,” Schaffner said.
Pfizer announced this week that its COVID-19 vaccine is 90% effective. The next big problem is: when will other people start receiving it?
Due to limited dose availability, the vaccine will be given first to certain groups.
If the FDA grants Pfizer an Emergency Use Authorization (USA). U. S. ), This procedure may begin with physical care staff and the first to respond in December.
Other parts of the population, such as staff and high-risk people, would likely see a vaccine around February or March.
The general population can see that doses move in half or behind in 2021.
The new coronavirus 2019 (COVID-19) is a new type of coronavirus Learn all about this type of coronavirus and how to contract and . . .
The new coronavirus outbreak first known in China has a pandemic. Stay up to date with the latest updates on COVID-19.
This is how a growing amount of clinical evidence shows us that wearing a mask is one of the most effective things we can do to prevent the spread . . .
Here are undeniable strategies you can use at home to make your own fabric mask with a clearing to prevent the spread of COVID-19.
Although evidence of the effect of physical (social) estating is still limited, early knowledge recommends that you have not reduced the number of infections.
Self-quarantine can be difficult, but dealing with it is impossible.
There’s a between being careful and being compulsive.
A pandemic is an epidemic that affects everyone. The World Health Organization has criteria for determining when an epidemic becomes a pandemic.
Your smartphone doesn’t have to be an inexhaustible source of anxiety.
Phenochromocytoma (PCC) is a rare tumor that bureaucracys in the middle of the adrenal glands. Tumors produce too many adrenal glands.